Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biochim Biophys Acta ; 938(3): 334-44, 1988 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-3126815

RESUMO

Aflatoxin B1 permeates isolated rat hepatocytes by non-ionic diffusion. Its uptake is neither saturable nor influenced by metabolic energy and not inhibited by treatment of cells with proteases. The initial rate of aflatoxin B1 uptake measured at 7 degrees C is between 40 and 50% compared to that at 37 degrees C. However, after an incubation period of 7 minutes identical equilibrium uptake is reached at both temperatures. The apparent activation energies, calculated for aflatoxin B1 uptake by Arrhenius diagrams ranged between 1.69 and 4.5 kcal/mol. A Q10 value of 1.34 was calculated for a temperature interval of 7-17 degrees C but decreased to 1.05 for the interval of 27-37 degrees C. Liposomes or lipoproteins added to the cell suspension inhibited the aflatoxin B1 uptake into hepatocytes. Liposomes mainly composed of unsaturated fatty acids bind twice as much aflatoxin B1 as those composed of saturated ones, indicating that the lipophilicity of the mycotoxin is crucial in the determination of its uptake into liver cells. At concentrations above 5 micrograms/ml, aflatoxin B1 inhibited the carrier-mediated uptake of cholic acid and of phalloidin into hepatocytes. This effect was reversible and abolished by washing the cells after preincubation with aflatoxin. In concentrations below 5 micrograms/ml the uptake of phallotoxin and cholic acid was however stimulated by 15-25%. These results indicate, that a carrier-mediated uptake into hepatocytes via the multispecific bile salt transporter is not responsible for the organoselective clearance of aflatoxins by the liver. On the other hand, the cholestatic effect of aflatoxin B1 results at least partially from the inhibition of the multispecific bile acid transport system. This inhibition may arise from affinity of aflatoxins to lipid domains of the cell membrane.


Assuntos
Aflatoxinas/farmacocinética , Ácidos e Sais Biliares/metabolismo , Fígado/metabolismo , Lipídeos de Membrana/metabolismo , Aflatoxina B1 , Aflatoxinas/farmacologia , Animais , Transporte Biológico/efeitos dos fármacos , Carcinógenos , Ácido Cólico , Ácidos Cólicos/metabolismo , Difusão , Cinética , Lipoproteínas/metabolismo , Lipossomos/metabolismo , Fígado/efeitos dos fármacos , Masculino , Oxigênio/farmacologia , Peptídeo Hidrolases/farmacologia , Permeabilidade , Faloidina/metabolismo , Ratos , Ratos Endogâmicos , Termodinâmica
2.
Mutat Res ; 223(3): 273-85, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2500594

RESUMO

For centuries green tea has been a widely consumed beverage throughout the world. It is known to contain a number of pharmacologically active compounds. In this study water extracts of green tea (WEGT) and their major constituents, green tea polyphenols (GTP), were examined for antimutagenic activity. WEGT and GTP were found to significantly inhibit the reverse mutation induced by benzo[alpha]pyrene (BP), aflatoxin B1 (AFB1), 2-aminofluorene, and methanol extracts of coal tar pitch in Salmonella typhimurium TA100 and/or TA98 in the presence of a rat-liver microsomal activation system. GTP also inhibited gene forward mutation in V79 cells treated with AFB1 and BP, and also decreased the frequency of sister-chromatid exchanges and chromosomal aberrations in V79 cells treated with AFB1. The addition of GTP during and after nitrosation of methylurea resulted in a dose-dependent inhibition of mutagenicity. Studies to define the mechanism of the antimutagenic activity of GTP suggest that it may affect carcinogen metabolism, DNA adduct formation, the interaction of ultimate carcinogen or the scavenging of free radicals.


Assuntos
Flavonoides , Mutagênicos/antagonistas & inibidores , Fenóis/farmacologia , Polímeros/farmacologia , Chá , Aflatoxina B1 , Aflatoxinas/farmacologia , Animais , Hidrocarboneto de Aril Hidroxilases/metabolismo , Benzo(a)pireno/metabolismo , Aberrações Cromossômicas , Cricetinae , Dano ao DNA , Radicais Livres , Microssomos/enzimologia , Testes de Mutagenicidade , Compostos Nitrosos , Polifenóis , Troca de Cromátide Irmã/efeitos dos fármacos
3.
Appl Environ Microbiol ; 37(3): 554-8, 1979 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-110264

RESUMO

The present study was conducted to determine whether or not aflatoxin B1 was an effective inducing agent for lysogenic bacteria and to characterize some of the parameters involved in induction. A lysogenic strain of Bacillus megaterium (NRRL-B-3695) and an indicator strain of this species (NRRL-B-3694) were used. Cultures of the lysogenic strain were incubated for various periods of time in the presence of aflatoxin B1. Plaque-forming units as well as colony-forming units were then determined. Results of the present study indicated that bacteriophage lysogenizing B. megaterium could be induced with aflatoxin B1. The optimum concentration for induction was 25 micrograms of toxin per ml of early-log-phase culture. Evidence suggested that: (i) higher concentrations of aflatoxin B1 formed hydrophobic complexes which would not efficiently induce B. megaterium; (ii) the toxic effect of aflatoxin B1 severely limited the number of cells which could be induced prior to killing action of the toxin; and (iii) concentrations less than 25 micrograms of aflatoxin B1 per ml were not efficient inducers of bacteriophage production nor did they demonstrate the toxic effect observed at higher concentrations.


Assuntos
Aflatoxinas/farmacologia , Bacillus megaterium/efeitos dos fármacos , Bacteriófagos/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Bacteriófagos/crescimento & desenvolvimento , Lisogenia , Polietilenoglicóis/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA